SHIONOGI AND MOLTENI CONCLUDE A CONTRACT FOR THE COMMERCIALIZATION OF RIZMOIC (NALDEMEDINE), AN OPIOID-INDUCED CONSTIPATION THERAPEUTIC AGENT IN ITALY AND POLAND
AMSTERDAM & FLORENCE, Italy--(BUSINESS WIRE)--May 22, 2019--
AMSTERDAM & FLORENCE, Italy--(BUSINESS WIRE)--May 22, 2019--